IBM Commits $30 Billion To R&D In US, Eyes Next-Level Advances In Mainframes And Quantum Computing

International Business Machines Corporation IBM disclosed a $150 billion investment plan in the U.S. over the next five years.

The initiative aims to drive economic growth and strengthen its position as a global computing leader.

In particular, the company plans to allocate over $30 billion toward research and development, focusing on advancing and expanding its American manufacturing of mainframe and quantum computers.

Also Read: IBM’s Shares Drop Sharply After Q1 Report: Analysts Say It’s Overdone, Revenue Growth To Accelerate

Arvind Krishna, IBM chairman, president and CEO said, “We have been focused on American jobs and manufacturing since our founding 114 years ago, and with this investment and manufacturing commitment we are ensuring that IBM remains the epicenter of the world’s most advanced computing and AI capabilities.”

In addition, the company unveiled new agentic and automation features in its managed detection and response services to enhance autonomous security operations and provide predictive threat intelligence for clients.

In particular, the company is introducing the Autonomous Threat Operations Machine (ATOM), an agentic AI system designed to autonomously handle threat triage, investigation, and remediation with minimal human input.

IBM is also launching the X-Force Predictive Threat Intelligence (PTI) agent for ATOM, which uses industry-specific AI foundation models to deliver predictive insights on potential adversarial activities and reduce the need for manual threat hunting.

This month, IBM reported first-quarter earnings of $1.60 per share, which exceeded the analyst consensus estimate of $1.40 and revenue of $14.54 billion, also surpassing the analyst consensus estimate of $ 14.40 billion.

Investors can gain exposure to the stock via First Trust NASDAQ Technology Dividend Index Fund TDIV and FT Vest Technology Dividend Target Income ETF TDVI.

Price Action: IBM shares are up 0.16% at $232.79 premarket at the last check Monday.

Read Next: